The Antiglaucoma Agent and EP2 Receptor Agonist Omidenepag Does Not Affect Eyelash Growth in Mice
Esaki Y., Katsuta O., Kamio H., Noto T., Mano H., Iwamura R., Yoneda K., Odani-Kawabata N., Morishima K., Shams N.K.
View publication
-
Therapeutic Area
Glaucoma
-
Technology
Pharmacology
-
Categories
Preclinical development
-
Affiliations
Santen Pharmaceutical Co Ltd., Research and Development Division, 8916-16 Takayama-cho, Ikoma-shi Nara, 630-0101, Japan; Ube Industries Ltd., Pharmaceuticals Research Laboratory, Pharmaceutical Division, Yamaguchi, Japan; Santen Pharmaceutical Co Ltd., Osaka, Japan; Santen Inc., Research and Development Division, Emeryville, CA, United States